share_log

The 9.7% Return This Week Takes Everjoy Health Group's (SZSE:002162) Shareholders Five-year Gains to 52%

The 9.7% Return This Week Takes Everjoy Health Group's (SZSE:002162) Shareholders Five-year Gains to 52%

本週9.7%的回報率使Everjoy Health Group(深圳證券交易所:002162)股東的五年漲幅達到52%
Simply Wall St ·  2023/10/31 19:25

When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, the Everjoy Health Group Co., Ltd. (SZSE:002162) share price is up 52% in the last 5 years, clearly besting the market return of around 32% (ignoring dividends). However, more recent returns haven't been as impressive as that, with the stock returning just 16% in the last year.

當我們投資時,我們通常會尋找表現優於市場平均水準的股票。事實是,如果你以合適的價格收購質量好的企業,你可以獲得巨大的收益。例如,長榮健康集團有限公司。(SZSE:002162)股價在過去5年中上漲了52%,顯然超過了約32%的市場回報率(不考慮股息)。然而,最近的回報沒有那麼令人印象深刻,該股去年的回報率僅為16%。

The past week has proven to be lucrative for Everjoy Health Group investors, so let's see if fundamentals drove the company's five-year performance.

事實證明,過去一週對EverJoy Health Group的投資者來說是有利可圖的,所以讓我們看看基本面因素是否推動了該公司五年的業績。

See our latest analysis for Everjoy Health Group

查看我們對EverJoy Health Group的最新分析

Because Everjoy Health Group made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

由於EverJoy Health Group在過去12個月中出現虧損,我們認為市場可能更關注收入和收入增長,至少目前是這樣。一般來說,沒有利潤的公司預計每年都會有收入增長,而且增長速度很快。這是因為快速的收入增長可以很容易地推斷出預期利潤,通常是相當大的規模。

In the last 5 years Everjoy Health Group saw its revenue grow at 4.2% per year. Put simply, that growth rate fails to impress. The modest growth is probably broadly reflected in the share price, which is up 9%, per year over 5 years. We'd be looking for the underlying business to grow revenue a bit faster.

在過去的5年裡,長榮健康集團的收入以每年4.2%的速度增長。簡而言之,這種增長速度未能給人留下深刻印象。這種溫和的增長可能大致反映在股價上,在過去5年中,股價以每年9%的速度上漲。我們希望基礎業務能夠更快地實現收入增長。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下圖描述了收益和收入隨時間的變化(通過單擊圖像來揭示確切的價值)。

earnings-and-revenue-growth
SZSE:002162 Earnings and Revenue Growth October 31st 2023
深圳證交所:002162收益和收入增長2023年10月31日

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

資產負債表的強健至關重要。也許很值得一看我們的免費報告其財務狀況如何隨著時間的推移而發生變化。

A Different Perspective

不同的視角

We're pleased to report that Everjoy Health Group shareholders have received a total shareholder return of 16% over one year. That gain is better than the annual TSR over five years, which is 9%. Therefore it seems like sentiment around the company has been positive lately. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. It's always interesting to track share price performance over the longer term. But to understand Everjoy Health Group better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Everjoy Health Group , and understanding them should be part of your investment process.

我們很高興地報告,EverJoy Health Group的股東在一年內獲得了16%的總股東回報。這一收益好於過去五年的年度TSR,後者為9%。因此,最近圍繞該公司的情緒似乎一直是積極的。持樂觀觀點的人可能會認為,最近TSR的改善表明,業務本身正在隨著時間的推移而變得更好。跟蹤股價的長期表現總是很有趣的。但要更好地瞭解恆大健康集團,我們還需要考慮許多其他因素。例如,考慮一下無處不在的投資風險幽靈。我們已經確定了1個警告信號與EverJoy Health Group合作,瞭解他們應該是您投資過程的一部分。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

如果你喜歡和管理層一起買股票,那麼你可能會喜歡這本書免費公司名單.(提示:內部人士一直在買入這些股票)。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論